{"id":47265,"title":"[New molecular targeting drugs for metastatic colorectal cancer].","abstract":"I explain an outline of the molecular target of new drugs for colorectal cancer. First, regorafenib is an orally active, multikinase inhibitor. Second, as angiogenesis inhibitors, aflibercept and ramucirumab. Aflibercept is the second anti-angiogenic agent after bevacizumab with a FDA approval for metastatic colorectal cancer. Ramucirumab is a fully human mAb that binds human VEGFR-2, thus blocking VEGF binding and inhibiting angiogenesis. Finally, I introduce a new combination chemotherapy regimen with molecular targetting drugs.","date":"2014-03-06","categories":"Digestive System Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24597359","annotations":[{"name":"Bevacizumab","weight":0.906986,"wikipedia_article":"http://en.wikipedia.org/wiki/Bevacizumab"},{"name":"Colorectal cancer","weight":0.870996,"wikipedia_article":"http://en.wikipedia.org/wiki/Colorectal_cancer"},{"name":"Angiogenesis","weight":0.844161,"wikipedia_article":"http://en.wikipedia.org/wiki/Angiogenesis"},{"name":"Kinase insert domain receptor","weight":0.813027,"wikipedia_article":"http://en.wikipedia.org/wiki/Kinase_insert_domain_receptor"},{"name":"Chemotherapy","weight":0.809719,"wikipedia_article":"http://en.wikipedia.org/wiki/Chemotherapy"},{"name":"Food and Drug Administration","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Food_and_Drug_Administration"},{"name":"Monoclonal antibodies","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Monoclonal_antibodies"},{"name":"Vascular endothelial growth factor","weight":0.785624,"wikipedia_article":"http://en.wikipedia.org/wiki/Vascular_endothelial_growth_factor"},{"name":"Colon (anatomy)","weight":0.744486,"wikipedia_article":"http://en.wikipedia.org/wiki/Colon_(anatomy)"},{"name":"Metastasis","weight":0.74084,"wikipedia_article":"http://en.wikipedia.org/wiki/Metastasis"},{"name":"Enzyme inhibitor","weight":0.72904,"wikipedia_article":"http://en.wikipedia.org/wiki/Enzyme_inhibitor"},{"name":"Cancer","weight":0.701843,"wikipedia_article":"http://en.wikipedia.org/wiki/Cancer"},{"name":"Angiogenesis inhibitor","weight":0.583251,"wikipedia_article":"http://en.wikipedia.org/wiki/Angiogenesis_inhibitor"},{"name":"AIDS","weight":0.577076,"wikipedia_article":"http://en.wikipedia.org/wiki/AIDS"},{"name":"Mouth","weight":0.486317,"wikipedia_article":"http://en.wikipedia.org/wiki/Mouth"},{"name":"Receptor antagonist","weight":0.455046,"wikipedia_article":"http://en.wikipedia.org/wiki/Receptor_antagonist"},{"name":"Chemotherapy regimens","weight":0.445377,"wikipedia_article":"http://en.wikipedia.org/wiki/Chemotherapy_regimens"},{"name":"Molecule","weight":0.311837,"wikipedia_article":"http://en.wikipedia.org/wiki/Molecule"},{"name":"Human","weight":0.291175,"wikipedia_article":"http://en.wikipedia.org/wiki/Human"},{"name":"Drug","weight":0.281015,"wikipedia_article":"http://en.wikipedia.org/wiki/Drug"},{"name":"History of cancer chemotherapy","weight":0.135948,"wikipedia_article":"http://en.wikipedia.org/wiki/History_of_cancer_chemotherapy"},{"name":"VEGF receptors","weight":0.0633182,"wikipedia_article":"http://en.wikipedia.org/wiki/VEGF_receptors"},{"name":"World War I","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/World_War_I"},{"name":"Molecular binding","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Molecular_binding"}]}
